High neutrophil to lymphocyte ratio with type 2 diabetes mellitus predicts poor prognosis in patients undergoing percutaneous coronary intervention: a large-scale cohort study
- PMID: 35964050
- PMCID: PMC9375260
- DOI: 10.1186/s12933-022-01583-9
High neutrophil to lymphocyte ratio with type 2 diabetes mellitus predicts poor prognosis in patients undergoing percutaneous coronary intervention: a large-scale cohort study
Abstract
Background: Inflammation plays a crucial role in the pathogenesis and progression of coronary artery disease (CAD). The neutrophil to lymphocyte ratio (NLR) is a novel inflammatory biomarker and its association with clinical outcomes in CAD patients with different glycemic metabolism after percutaneous coronary intervention (PCI) remains undetermined. Therefore, this study aimed to investigate the effect of NLR on the prognosis of patients undergoing PCI with or without type 2 diabetes mellitus (T2DM).
Methods: We consecutively enrolled 8,835 patients with CAD hospitalized for PCI at Fuwai hospital. NLR was calculated using the following formula: neutrophil (*109/L)/lymphocyte (*109/L). According to optimal cut-off value, study patients were categorized as higher level of NLR (NLR-H) and lower level of NLR (NLR-L) and were further stratified as NLR-H with T2DM and non-T2DM, and NLR-L with T2DM and non-T2DM. The primary endpoint was major adverse cardiovascular and cerebrovascular events (MACCEs), defined as all-cause mortality, myocardial infarction (MI), stroke and target vessel revascularization.
Results: A total of 674 (7.6%) MACCEs were recorded during a median follow-up of 2.4 years. The optimal cut-off value of NLR was 2.85 determined by the surv_cutpoint function. Compared to those in the NLR-H/T2DM groups, patients in the NLR-L/non-T2DM, NLR-H/non-T2DM and NLR-L/T2DM groups were at significantly lower risk of 2-year MACCEs [adjusted hazard ratio (HR): 0.67, 95% confidence interval (CI): 0.52 to 0.87, P = 0.003; adjusted HR: 0.62, 95%CI: 0.45 to 0.85, P = 0.003; adjusted HR: 0.77, 95%CI: 0.61 to 0.97, P = 0.025; respectively]. Remarkably, patients in the NLR-L/non-T2DM group also had significantly lower risk of a composite of all-cause mortality and MI than those in the NLR-H/T2DM group (adjusted HR: 0.57, 95%CI: 0.35 to 0.93, P = 0.024). Multivariable Cox proportional hazards model also indicated the highest risk of MACCEs in diabetic patients with higher level of NLR than others (P for trend = 0.009). Additionally, subgroup analysis indicated consistent impact of NLR on MACCEs across different subgroups.
Conclusions: Presence of T2DM with elevated NLR is associated with worse clinical outcomes in CAD patients undergoing PCI. Categorization of patients with elevated NLR and T2DM could provide valuable information for risk stratification of CAD patients.
Keywords: Coronary artery disease; Diabetes; Neutrophil‑to‑lymphocyte ratio; Percutaneous coronary intervention; Prognosis.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
High absolute neutrophil count with type 2 diabetes is associated with adverse outcome in patients with coronary artery disease: A large-scale cohort study.Front Endocrinol (Lausanne). 2023 Apr 11;14:1129633. doi: 10.3389/fendo.2023.1129633. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37113481 Free PMC article.
-
High fibrinogen-to-albumin ratio with type 2 diabetes mellitus is associated with poor prognosis in patients undergoing percutaneous coronary intervention: 5-year findings from a large cohort.Cardiovasc Diabetol. 2022 Mar 21;21(1):46. doi: 10.1186/s12933-022-01477-w. Cardiovasc Diabetol. 2022. PMID: 35313877 Free PMC article.
-
The atherogenic index of plasma plays an important role in predicting the prognosis of type 2 diabetic subjects undergoing percutaneous coronary intervention: results from an observational cohort study in China.Cardiovasc Diabetol. 2020 Feb 21;19(1):23. doi: 10.1186/s12933-020-0989-8. Cardiovasc Diabetol. 2020. PMID: 32085772 Free PMC article.
-
Predictive value of neutrophil to lymphocyte ratio in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: a meta-analysis.BMC Cardiovasc Disord. 2018 May 2;18(1):75. doi: 10.1186/s12872-018-0812-6. BMC Cardiovasc Disord. 2018. PMID: 29716535 Free PMC article. Review.
-
Comparing the adverse clinical outcomes in patients with non-insulin treated type 2 diabetes mellitus and patients without type 2 diabetes mellitus following percutaneous coronary intervention: a systematic review and meta-analysis.BMC Cardiovasc Disord. 2016 Nov 25;16(1):238. doi: 10.1186/s12872-016-0422-0. BMC Cardiovasc Disord. 2016. PMID: 27887590 Free PMC article. Review.
Cited by
-
The value of neutrophil-to-lymphocyte ratio in predicting severity of coronary involvement and long-term outcome of percutaneous coronary intervention in patients with acute coronary syndrome: a systematic review and meta-analysis.Egypt Heart J. 2024 Mar 28;76(1):39. doi: 10.1186/s43044-024-00469-3. Egypt Heart J. 2024. PMID: 38546902 Free PMC article. Review.
-
SLC25A17 inhibits autophagy to promote triple-negative breast cancer tumorigenesis by ROS-mediated JAK2/STAT3 signaling pathway.Cancer Cell Int. 2024 Feb 24;24(1):85. doi: 10.1186/s12935-024-03270-z. Cancer Cell Int. 2024. PMID: 38402166 Free PMC article.
-
Triglyceride-glucose index as a suitable non-insulin-based insulin resistance marker to predict cardiovascular events in patients undergoing complex coronary artery intervention: a large-scale cohort study.Cardiovasc Diabetol. 2024 Jan 6;23(1):15. doi: 10.1186/s12933-023-02110-0. Cardiovasc Diabetol. 2024. PMID: 38184591 Free PMC article.
-
Glycemic control and cardiovascular outcomes in patients with diabetes and coronary artery disease according to triglyceride-glucose index: a large-scale cohort study.Cardiovasc Diabetol. 2024 Jan 6;23(1):11. doi: 10.1186/s12933-023-02112-y. Cardiovasc Diabetol. 2024. PMID: 38184572 Free PMC article.
-
The Combined Effect of Systemic Immune-Inflammation Index and Type 2 Diabetes Mellitus on the Prognosis of Patients Undergoing Percutaneous Coronary Intervention: A Large-Scale Cohort Study.J Inflamm Res. 2023 Dec 27;16:6415-6429. doi: 10.2147/JIR.S445479. eCollection 2023. J Inflamm Res. 2023. PMID: 38164165 Free PMC article.
References
-
- Lawler PR, Bhatt DL, Godoy LC, et al. Targeting cardiovascular inflammation: next steps in clinical translation. Eur Heart J. 2021;42(1):113–131. - PubMed
-
- Drechsler M, Döring Y, Megens RTA, Soehnlein O. Neutrophilic granulocytes - promiscuous accelerators of atherosclerosis. Thromb Haemost. 2011;106(5):839–848. - PubMed
-
- Sabatine MS, Morrow DA, Cannon CP, et al. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy- Thrombolysis in Myocardial Infarction 18 trial) substudy. J Am Coll Cardiol. 2002;40(10):1761–1768. doi: 10.1016/S0735-1097(02)02484-1. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous